Alzheimer’s Disease: Black Americans Are Hardest Hit

As the aging population continues to grow, so will the prevalence of Alzheimer’s disease and worse yet, Blacks will be hit hardest. According to the Alzheimer’s Association’s 2018 Alzheimer’s Disease Facts and Figures, an estimated 5.2 million Americans have Alzheimer’s disease and 1.1 million of them are Black-American. Alzheimer’s disease is currently ranked as the sixth…

Informed Consent

This document is produced by the CEAL Inclusive Participation Group for investigators and trialists as best practices to maximize engagement, dispel misinformation and foster trust. The priority populations for these trials are minorities and the elderly. The purpose of informed consent it to ensure that a volunteer can make an informed choice about taking part,…

Shifting the Drug Development Paradigm

As new technologies emerge, an opportunity to radically change clinical trials from site-centric to patient-centric has presented itself. Mereck’s (Kenilworth, NJ) digitally enabled clinical trial initiative is focused on reducing patient burden and increasing patient engagement. The four areas of focus in this paper are: use of technologies that can monitor drug adherence (smart dosing),…